Class I HDAC inhibitors enhance antitumor efficacy and persistence of CAR-T cells by activation of the Wnt pathway
Article in Cell Reports (April 2024)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
Article in Cell Reports (April 2024)
Article in Frontiers in Oncology (March 2024)
Article in Cancers (February 2024)